An overview of peptide and peptoid foldamers in medicinal chemistry

Expert Opinion on Drug Discovery

Volumn 10, Issue 11, 2015, Pages 1163-1177

  Mándity, István M ^a   Fülöp, Ferenc ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

antibacterial; arylamide foldamer; helix; medicinal chemical application; peptoid; protein protein interaction; strand; peptide

Indexed keywords

AMYLOID BETA PROTEIN; ANTIINFECTIVE AGENT; CELL PENETRATING PEPTIDE; PEPTIDE; PEPTOID; PEPTOID FOLDAMER; UNCLASSIFIED DRUG;

AUTOPHAGY; HUMAN; MEDICINAL CHEMISTRY; MEMBRANE BINDING; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; ANIMAL; BIOAVAILABILITY; CHEMISTRY; DRUG DESIGN; PROCEDURES; PROTEIN SECONDARY STRUCTURE;

ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; HUMANS; PEPTIDES; PEPTOIDS; PROTEIN FOLDING; PROTEIN STRUCTURE, SECONDARY;

EID: 84946500622     PISSN: 17460441     EISSN: 1746045X     Source Type: Journal    
DOI: 10.1517/17460441.2015.1076790     Document Type: Review

References (141)

1. Gellman SH. Foldamers: A manifesto. Acc Chem Res 1998;31(4):173-80
2. Cheng RP, Gellman SH, DeGrado WF. beta-peptides: From structure to function. Chem Rev 2001;101(10):3219-32
3. Martinek TA, Fulop F. Peptidic foldamers: ramping up diversity. Chem Soc Rev 2012;41(2):687-702
4. Fulop F, Martinek TA, Toth GK. Application of alicyclic beta-amino acids in peptide chemistry. Chem Soc Rev 2006;35(4):323-34
5. Goodman CM, Choi S, Shandler S, et al. Foldamers as versatile frameworks for the design and evolution of function. Nat Chem Biol 2007;3(5):252-62
6. Seebach D, Beck AK, Bierbaum DJ. The World of beta- and γ-Peptides Comprised of Homologated Proteinogenic Amino Acids and Other Components. Chem Biodev 2004;1(8):1111-239
7. Seebach D, L Matthews J. beta-Peptides: a surprise at every turn. Chem Commun 1997;21:2015-22
8. Seebach D, Overhand M, Kuhnle FNM, et al. beta-peptides: Synthesis by Arndt-Eistert homologation with concomitant peptide coupling. Structure determination by NMR and CD spectroscopy and by X-ray crystallography. Helical secondary structure of a beta-hexapeptide in solution and its stability towards pepsin. Helv Chim Acta 1996;79(4):913-41
9. Mandity IM, Weber E, Martinek TA, et al. Design of Peptidic Foldamer Helices: A Stereochemical Patterning Approach. Angew Chem Int Ed 2009;48(12):2171-5
10. Mandity IM, Fulop L, Vass E, et al. Building beta-Peptide H10/12 Foldamer Helices with Six-Membered Cyclic Side-Chains: Fine-Tuning of Folding and Self-Assembly. Org Lett 2010;12(23):5584-7
11. Martinek TA, Mandity IM, Fulop L, et al. Effects of the alternating backbone configuration on the secondary structure and self-assembly of beta-peptides. J Am Chem Soc 2006;128(41):13539-44
12. Mándity IM, Olasz B, Ötvös SB, et al. Continuous-Flow Solid-Phase Peptide Synthesis: A Revolutionary Reduction of the Amino Acid Excess. ChemSusChem 2014;7(11):3172-6
13. Wender PA, Mitchell DJ, Pattabiraman K, et al. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters. Proc Nat Acad Sci USA 2000;97(24):13003-8
14. Simon RJ, Kania RS, Zuckermann RN, et al. Peptoids - A modular approach to drug discovery. Proc Nat Acad Sci USA 1992;89(20):9367-71
15. Stringer JR, Crapster JA, Guzei IA, et al. Extraordinarily Robust Polyproline Type I Peptoid Helices Generated via the Incorporation of alpha-Chiral Aromatic N-1-Naphthylethyl Side Chains. J Am Chem Soc 2011;133(39):15559-67
16. Gorske BC, Stringer JR, Bastian BL, et al. New Strategies for the Design of Folded Peptoids Revealed by a Survey of Noncovalent Interactions in Model Systems. J Am Chem Soc 2009;131(45):16555-67
17. Gorske BC, Bastian BL, Geske GD, et al. Local and tunable n ->pi∗ interactions regulate amide isomerism in the peptoid backbone. J Am Chem Soc 2007;129(29):8928-9
18. Fowler SA, Blackwell HE. Structure-function relationships in peptoids: Recent advances toward deciphering the structural requirements for biological function. Org Biomol Chem 2009;7(8):1508-24
19. Huc I. Aromatic oligoamide foldamers. Eur J Org Chem 2004(1):17-29
20. Shirude PS, Gillies ER, Ladame S, et al. Macrocyclic and helical oligoamides as a new class of g-quadruplex ligands. J Am Chem Soc 2007;129(39):11890-1
21. Guichard G, Huc I. Synthetic foldamers. Chem Commun 2011;47(21):5933-41
22. Arvidsson PI, Rueping M, Seebach D. Design, machine synthesis, and NMR-solution structure of a beta-heptapeptide forming a salt-bridge stabilised 3(14)-helix in methanol and in water. Chem Commun 2001;7:649-50
23. Seebach D, Gademann K, Schreiber JV, et al. 'Mixed' beta-peptides: A unique helical secondary structure in solution. Helv Chim Acta 1997;80(7):2033-8
24. Pammolli F, Magazzini L, Riccaboni M. The productivity crisis in pharmaceutical R&D. Nat Rev Drug Discov 2011;10(6):428-38
25. Keseru GM, Soos T, Kappe CO. Anthropogenic reaction parameters - the missing Link between chemical intuition and the available chemical space. Chem Soc Rev 2014;43(15):5387-99
26. Lee B-C, Zuckermann RN. Protein Side-Chain Translocation Mutagenesis via Incorporation of Peptoid Residues. ACS Chem Biol 2011;6(12):1367-74
27. Cabrele C, Martinek TA, Reiser O, et al. Peptides Containing bata-Amino Acid Patterns: Challenges and Successes in Medicinal Chemistry. J Med Chem 2014;57(23):9718-39
28. Yin H, Hamilton AD. Strategies for targeting protein-protein interactions with synthetic agents. Angew Chem Int Ed 2005;44(27):4130-63
29. Peczuh MW, Hamilton AD. Peptide and protein recognition by designed molecules. Chem Rev 2000;100(7):2479-93
30. Azzarito V, Long K, Murphy NS, et al. Inhibition of alpha-helix-mediated protein-protein interactions using designed molecules. Nat Chem 2013;5(3):161-73
31. Scifinder, version 2015.1; Chemical Abstracts Service: Columbus, OH, 2015. [Last accessed April 15, 2015
32. Oren Z, Shai Y. Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Pept Sci 1998;47(6):451-63
33. Tossi A, Sandri L, Giangaspero A. Amphipathic, alpha-helical antimicrobial peptides. Pept Sci 2000;55(1):4-30
34. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415(6870):389-95
35. DeGrado WF, Musso GF, Lieber M, et al. Kinetics and mechanism of hemolysis induced by melittin and by a synthetic melittin analogue. Biophys J 1982;37(1):329-38
36. Chongsiriwatana NP, Patch JA, Czyzewski AM, et al. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides. Proc Natl Acad Sci USA 2008;105(8):2794-9
37. Ghosh C, Manjunath GB, Akkapeddi P, et al. Small Molecular Antibacterial Peptoid Mimics: The Simpler the Better!. J Med Chem 2014;57(4):1428-36
38. Goodson B, Ehrhardt A, Ng S, et al. Characterization of Novel Antimicrobial Peptoids. Antimicrob Agents Chemother 1999;43(6):1429-34
39. Patch JA, Barron AE. Helical Peptoid Mimics of Magainin-2 Amide. J Am Chem Soc 2003;125(40):12092-3
40. Tan NC, Yu P, Kwon Y-U, et al. High-throughput evaluation of relative cell permeability between peptoids and peptides. Bioorg Med Chem 2008;16(11):5853-61
41. Seo J, Ren G, Liu H, et al. In Vivo Biodistribution and Small Animal PET of 64Cu-Labeled Antimicrobial Peptoids. Bioconj Chem 2012;23(5):1069-79
42. Gorske BC, Blackwell HE. Interception of quorum sensing in Staphylococcus aureus: a new niche for peptidomimetics. Org Biomol Chem 2006;4(8):1441-5
43. Arvidsson PI, Ryder NS, Weiss HM, et al. Antibiotic and Hemolytic Activity of a beta2/beta3 Peptide Capable of Folding into a 12/10-Helical Secondary Structure. ChemBioChem 2003;4(12):1345-7
44. Arvidsson PI, Frackenpohl J, Ryder NS, et al. On the Antimicrobial and Hemolytic Activities of Amphiphilic beta-Peptides. ChemBioChem 2001;2(10):771-3
45. Hamuro Y, Schneider JP, DeGrado WF. De Novo Design of Antibacterial beta-Peptides. J Am Chem Soc 1999;121(51):12200-1
46. Liu D, DeGrado WF. De Novo Design, Synthesis, and Characterization of Antimicrobial beta-Peptides. J Am Chem Soc 2001;123(31):7553-9
47. Porter EA, Wang X, Lee H-S, et al. Antibiotics: Non-haemolytic beta-amino-acid oligomers. Nature 2000;404(6778):565-5
48. Epand RF, Raguse L, Gellman SH, et al. Antimicrobial 14-Helical beta-Peptides: Potent Bilayer Disrupting Agents. Biochem 2004;43(29):9527-35
49. Raguse TL, Porter EA, Weisblum B, et al. Structure-Activity Studies of 14-Helical Antimicrobial beta-Peptides: Probing the Relationship between Conformational Stability and Antimicrobial Potency. J Am Chem Soc 2002;124(43):12774-85
50. Porter EA, Weisblum B, Gellman SH. Use of Parallel Synthesis To Probe Structure-Activity Relationships among 12-Helical beta-Peptides: Evidence of a Limit on Antimicrobial Activity. J Am Chem Soc 2005;127(32):11516-29
51. Brogden KA. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Micro 2005;3(3):238-50
52. Mowery BP, Lee SE, Kissounko DA, et al. Mimicry of Antimicrobial Host-Defense Peptides by Random Copolymers. J Am Chem Soc 2007;129(50):15474-6
53. Epand RF, Mowery BP, Lee SE, et al. Dual Mechanism of Bacterial Lethality for a Cationic Sequence-Random Copolymer that Mimics Host-Defense Antimicrobial Peptides. J Mol Biol 2008;379(1):38-50
54. Schmitt MA, Weisblum B, Gellman SH. Interplay among Folding, Sequence, and Lipophilicity in the Antibacterial and Hemolytic Activities of alpha/beta-Peptides. J Am Chem Soc 2007;129(2):417-28
55. Schmitt MA, Weisblum B, Gellman SH. Unexpected Relationships between Structure and Function in alpha,beta-Peptides: Antimicrobial Foldamers with Heterogeneous Backbones. J Am Chem Soc 2004;126(22):6848-9
56. Mensa B, Kim YH, Choi S, et al. Antibacterial Mechanism of Action of Arylamide Foldamers. Antimicrob Agents Chemother 2011;55(11):5043-53
57. Tew GN, Scott RW, Klein ML, et al. De Novo Design of Antimicrobial Polymers, Foldamers, and Small Molecules: From Discovery to Practical Applications. Acc Chem Res 2010;43(1):30-9
58. Doerksen RJ, Chen B, Liu D, et al. Controlling the Conformation of Arylamides: Computational Studies of Intramolecular Hydrogen Bonds between Amides and Ethers or Thioethers. Chem Eur J 2004;10(20):5008-16
59. Tew GN, Liu D, Chen B, et al. De novo design of biomimetic antimicrobial polymers. Proc Natl Acad Sci USA 2002;99(8):5110-14
60. Liu D, Choi S, Chen B, et al. Nontoxic Membrane-Active Antimicrobial Arylamide Oligomers. Angew Chem Int Ed 2004;43(9):1158-62
61. Kang JH, Lee MK, Kim KL, et al. Structure-biological activity relationships of 11-residue highly basic peptide segment of bovine lactoferrin. Int J Pept Protein Res 1996;48(4):357-63
62. Huc I. Aromatic Oligoamide Foldamers. Eur J Org Chem 2004;2004(1):17-29
63. Choi S, Isaacs A, Clements D, et al. De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers. Proc Natl Acad Sci USA 2009;106(17):6968-73
64. Copolovici DM, Langel K, Eriste E, et al. Cell-Penetrating Peptides: Design, Synthesis, and Applications. ACS Nano 2014;8(3):1972-94
65. Kwon Y-U, Kodadek T. Quantitative Evaluation of the Relative Cell Permeability of Peptoids and Peptides. J Am Chem Soc 2007;129(6):1508-9
66. Unciti-Broceta A, Diezmann F, Ou-Yang CY, et al. Synthesis, penetrability and intracellular targeting of fluorescein-tagged peptoids and peptide - peptoid hybrids. Bioorg Med Chem 2009;17(3):959-66
67. Lee J, Udugamasooriya DG, Lim H-S, et al. Potent and selective photo-inactivation of proteins with peptoid-ruthenium conjugates. Nat Chem Biol 2010;6(4):258-60
68. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9(6):669-76
69. Winterle JS, Kliger DS, Hammond GS. Mechanisms of photochemical reactions in solution. 80. Photochemical oxidation of tris(2,2′-bipyridyl)ruthenium(II) by molecular oxygen. J Am Chem Soc 1976;98(12):3719-21
70. Utku Y, Dehan E, Ouerfelli O, et al. A peptidomimetic siRNA transfection reagent for highly effective gene silencing. Molecular BioSyst 2006;2(6-7):312-17
71. Lobo BA, Vetro JA, Suich DM, et al. Structure/function analysis of peptoid/lipitoid:DNA complexes. J Pharm Sci 2003;92(9):1905-18
72. Rajasekhar K, Narayanaswamy N, Mishra P, et al. Synthesis of Hybrid Cyclic Peptoids and Identification of Autophagy Enhancer. ChemPlusChem 2014;79(1):25-30
73. Gelman MA, Richter S, Cao H, et al. Selective Binding of TAR RNA by a Tat-Derived beta-Peptide. Org Lett 2003;5(20):3563-5
74. Potocky TB, Menon AK, Gellman SH. Cytoplasmic and Nuclear Delivery of a TAT-derived Peptide and a beta-Peptide after Endocytic Uptake into HeLa Cells. J Biol Chem 2003;278(50):50188-94
75. Rueping M, Mahajan Y, Sauer M, et al. Cellular Uptake Studies with beta-Peptides. ChemBioChem 2002;3(2-3):257-9
76. Potocky TB, Silvius J, Menon AK, et al. HeLa Cell Entry by Guanidinium-Rich beta-Peptides: Importance of Specific Cation-Cell Surface Interactions. ChemBioChem 2007;8(8):917-26
77. Eldred SE, Pancost MR, Otte KM, et al. Effects of Side Chain Configuration and Backbone Spacing on the Gene Delivery Properties of Lysine-Derived Cationic Polymers. Bioconj Chem 2005;16(3):694-9
78. Bautista AD, Appelbaum JS, Craig CJ, et al. Bridged beta3-Peptide Inhibitors of p53-hDM2 Complexation: Correlation between Affinity and Cell Permeability. J Am Chem Soc 2010;132(9):2904-6
79. Kamena F, Monnanda B, Makou D, et al. On the Mechanism of Eukaryotic Cell Penetration by alpha- and beta-Oligoarginines - Targeting Infected Erythro-cytes. Chem Biodev 2011;8(1):1-12
80. Sparr C, Purkayastha N, Kolesinska B, et al. Improved efficacy of fosmidomycin against Plasmodium and Mycobacterium species by combination with the cell penetrating peptide octaarginine. Antimicrob Agents Chemother 2013;DOI:10.1128/AAC.00427-13
81. Iriondo-Alberdi J, Laxmi-Reddy K, Bouguerne B, et al. Cellular Internalization of Water-Soluble Helical Aromatic Amide Foldamers. ChemBioChem 2010;11(12):1679-85
82. Gao CM, Yam AY, Wang X, et al. Aβ40 Oligomers Identified as a Potential Biomarker for the Diagnosis of Alzheimer's Disease. PLoS One 2010;5(12):e15725
83. Reddy MM, Wilson R, Wilson J, et al. Identification of Candidate IgG Biomarkers for Alzheimer's Disease via Combinatorial Library Screening. Cell 2011;144(1):132-42
84. Imamura Y, Watanabe N, Umezawa N, et al. Inhibition of gamma-Secretase Activity by Helical beta-Peptide Foldamers. J Am Chem Soc 2009;131(21):7353-9
85. Imamura Y, Umezawa N, Osawa S, et al. Effect of Helical Conformation and Side Chain Structure on γ-Secretase Inhibition by beta-Peptide Foldamers: Insight into Substrate Recognition. J Med Chem 2013;56(4):1443-54
86. Fulop L, Mandity IM, Juhasz G, et al. A Foldamer-Dendrimer Conjugate Neutralizes Synaptotoxic beta-Amyloid Oligomers. Plos One 2012;7:7
87. Seither KM, McMahon HA, Singh N, et al. Specific aromatic foldamers potently inhibit spontaneous and seeded A beta 42 and A beta 43 fibril assembly. Biochem J 2014;464:85-98
88. Samaranayake H, Wirth T, Schenkwein D, et al. Challenges in monoclonal antibody-based therapies. Annals Med 2009;41(5):322-31
89. Chames P, Van Regenmortel M, Weiss E, et al. Therapeutic antibodies: successes, limitations and hopes for the future. Brit J Pharm 2009;157(2):220-33
90. Azzarito V, Long K, Murphy NS, et al. Inhibition of alpha-helix-mediated protein-protein interactions using designed molecules. Nat Chem 2013;5(3):161-73
91. Chène P. Inhibiting the p53-MDM2 interaction: an important target for cancer therapy. Nat Rev Cancer 2003;3(2):102-9
92. Hayashi R, Wang D, Hara T, et al. N-Acylpolyamine Inhibitors of HDM2 and HDMX Binding to p53. Bioorg Med Chem 2009;17(23):7884-93
93. Reddy MM, Bachhawat-Sikder K, Kodadek T. Transformation of Low-Affinity Lead Compounds into High-Affinity Protein Capture Agents. Chem Biol 2004;11(8):1127-37
94. Liu B, Alluri PG, Yu P, et al. A Potent Transactivation Domain Mimic with Activity in Living Cells. J Am Chem Soc 2005;127(23):8254-5
95. Alluri P, Liu B, Yu P, et al. Isolation and characterization of coactivator-binding peptoids from a combinatorial library. Mol BioSyst 2006;2(11):568-79
96. Lim H-S, Archer CT, Kodadek T. Identification of a Peptoid Inhibitor of the Proteasome 19S Regulatory Particle. J Am Chem Soc 2007;129(25):7750-1
97. Lim H-S, Archer CT, Kim Y-C, et al. Rapid identification of the pharmacophore in a peptoid inhibitor of the proteasome regulatory particle. Chem Commun 2008(9):1064-6
98. Trader DJ, Simanski S, Kodadek T. A Reversible and Highly Selective Inhibitor of the Proteasomal Ubiquitin Receptor Rpn13 Is Toxic to Multiple Myeloma Cells. J Am Chem Soc 2015;137(19):6312-19
99. Udugamasooriya DG, Dineen SP, Brekken RA, et al. A Peptoid "Antibody Surrogate" That Antagonizes VEGF Receptor 2 Activity. J Am Chem Soc 2008;130(17):5744-52
100. Udugamasooriya DG, Ritchie C, Brekken RA, et al. A peptoid antagonist of VEGF Receptor 2 recognizes a 'hotspot' in the extracellular domain distinct from the hormone-binding site. Bioorg Med Chem 2008;16(12):6338-43
101. Raveendra BL, Wu H, Baccala R, et al. Discovery of Peptoid Ligands for Anti-Aquaporin 4 Antibodies. Chem Bio 2013;20(3):351-9
102. Gao Y, Kodadek T. Direct Comparison of Linear and Macrocyclic Compound Libraries as a Source of Protein Ligands. ACS Comb Sci 2015;17(3):190-5
103. Kritzer JA, Lear JD, Hodsdon ME, et al. Helical beta-Peptide Inhibitors of the p53-hDM2 Interaction. J Am Chem Soc 2004;126(31):9468-9
104. Kritzer JA, Luedtke NW, Harker EA, et al. A Rapid Library Screen for Tailoring beta-Peptide Structure and Function. J Am Chem Soc 2005;127(42):14584-5
105. Michel J, Harker EA, Tirado-Rives J, et al. In Silico Improvement of beta(3)-Peptide Inhibitors of p53 center dot hDM2 and p53 center dot hDMX. J Am Chem Soc 2009;131(18):6356-7
106. Hintersteiner M, Kimmerlin T, Garavel G, et al. A Highly Potent and Cellularly Active beta-Peptidic Inhibitor of the p53/hDM2 Interaction. ChemBioChem 2009;10(6):994-8
107. Sadowsky JD, Schmitt MA, Lee H-S, et al. Chimeric (α/β + α)-Peptide Ligands for the BH3-Recognition Cleft of Bcl-xL: Critical Role of the Molecular Scaffold in Protein Surface Recognition. J Am Chem Soc 2005;127(34):11966-8
108. Sadowsky JD, Fairlie WD, Hadley EB, et al. (α/β+α)-Peptide Antagonists of BH3 Domain/Bcl-xL Recognition: Toward General Strategies for Foldamer-Based Inhibition of Protein-Protein Interactions. J Am Chem Soc 2007;129(1):139-54
109. Sadowsky JD, Murray JK, Tomita Y, et al. Exploration of Backbone Space in Foldamers Containing alpha- and beta-Amino Acid Residues: Developing Protease-Resistant Oligomers that Bind Tightly to the BH3-Recognition Cleft of Bcl-xL. ChemBioChem 2007;8(8):903-16
110. Lee EF, Sadowsky JD, Smith BJ, et al. High-Resolution Structural Characterization of a Helical alpha/beta-Peptide Foldamer Bound to the Anti-Apoptotic Protein Bcl-xL. Angew Chem Int Ed 2009;48(24):4318-22
111. Horne WS, Boersma MD, Windsor MA, et al. Sequence-Based Design of alpha/beta-Peptide Foldamers That Mimic BH3 Domains. Angew Chem Int Ed 2008;47(15):2853-6
112. Stephens OM, Kim S, Welch BD, et al. Inhibiting HIV Fusion with a beta-Peptide Foldamer. J Am Chem Soc 2005;127(38):13126-7
113. Horne WS, Johnson LM, Ketas TJ, et al. Structural and biological mimicry of protein surface recognition by alpha/beta-peptide foldamers. Proc Natl Acad Sci USA 2009;106(35):14751-6
114. Johnson LM, Horne WS, Gellman SH. Broad Distribution of Energetically Important Contacts across an Extended Protein Interface. J Am Chem Soc 2011;133(26):10038-41
115. Haase HS, Peterson-Kaufman KJ, Lan Levengood SK, et al. Extending Foldamer Design beyond alpha-Helix Mimicry: alpha/beta-Peptide Inhibitors of Vascular Endothelial Growth Factor Signaling. J Am Chem Soc 2012;134(18):7652-5
116. Yin H, Slusky JS, Berger BW, et al. Computational Design of Peptides That Target Transmembrane Helices. Science 2007;315(5820):1817-22
117. Shandler SJ, Korendovych IV, Moore DT, et al. Computational Design of a beta-Peptide That Targets Transmembrane Helices. J Am Chem Soc 2011;133(32):12378-81
118. Johnson LM, Barrick S, Hager MV, et al. A Potent alpha/beta-Peptide Analogue of GLP-1 with Prolonged Action in Vivo. J Am Chem Soc 2014;136(37):12848-51
119. Nunn C, Rueping M, Langenegger D, et al. beta2/beta3-di- and alpha/beta3-tetrapeptide derivatives as potent agonists at somatostatin sst4 receptors. Naunyn-Schmiedeberg's Arch Pharmacol 2003;367(2):95-103
120. Wiegand H, Wirz B, Schweitzer A, et al. Pharmacokinetic Investigation of a 14C-Labelled beta3/alpha Tetrapeptide in Rats. Chem Biodev 2004;1(11):1812-28
121. Trouche N, Wieckowski S, Sun W, et al. Small Multivalent Architectures Mimicking Homotrimers of the TNF Superfamily Member CD40L: Delineating the Relationship between Structure and Effector Function. J Am Chem Soc 2007;129(44):13480-92
122. Fournel S, Wieckowski S, Sun W, et al. C3-symmetric peptide scaffolds are functional mimetics of trimeric CD40L. Nat Chem Biol 2005;1(7):377-82
123. Hegedues Z, Weber E, Kriston-Pal E, et al. Foldameric alpha/beta-Peptide Analogs of the beta-Sheet-Forming Antiangiogenic Anginex: Structure and Bioactivity. J Am Chem Soc 2013;135(44):16578-84
124. Olajos G, Hetenyi A, Weber E, et al. Induced Folding of Protein-Sized Foldameric beta-Sandwich Models with Core beta-Amino Acid Residues. Chem Eur J 2015;21(16):6173-80
125. Reinert ZE, Lengyel GA, Horne WS. Protein-like Tertiary Folding Behavior from Heterogeneous Backbones. J Am Chem Soc 2013;135(34):12528-31
126. Lengyel GA, Horne WS. Design Strategies for the Sequence-Based Mimicry of Side-Chain Display in Protein beta-Sheets by alpha/beta-Peptides. J Am Chem Soc 2012;134(38):15906-13
127. Lengyel GA, Eddinger GA, Horne WS. Introduction of Cyclically Constrained gamma-Residues Stabilizes an alpha-Peptide Hairpin in Aqueous Solution. Org Lett 2013;15(4):944-7
128. Kar K, Hoop CL, Drombosky KW, et al. beta-Hairpin-Mediated Nucleation of Polyglutamine Amyloid Formation. J Mol Biol 2013;425(7):1183-97
129. Orner BP, Ernst JT, Hamilton AD. Toward Proteomimetics: Terphenyl Derivatives as Structural and Functional Mimics of Extended Regions of an alpha-Helix. J Am Chem Soc 2001;123(22):5382-3
130. Yin H, Lee G-i, Sedey KA, et al. Terephthalamide Derivatives as Mimetics of Helical Peptides: Disruption of the Bcl-xL/Bak Interaction. J Am Chem Soc 2005;127(15):5463-8
131. Ernst JT, Becerril J, Park HS, et al. Design and Application of an alpha-Helix-Mimetic Scaffold Based on an Oligoamide-Foldamer Strategy: Antagonism of the Bak BH3/Bcl-xL Complex. Angew Chem Int Ed 2003;42(5):535-9
132. Saraogi I, Hebda JA, Becerril J, et al. Synthetic alpha-Helix Mimetics as Agonists and Antagonists of Islet Amyloid Polypeptide Aggregation. Angew Chem Int Ed 2010;49(4):736-9
133. Yin H, Frederick KK, Liu D, et al. Arylamide Derivatives as Peptidomimetic Inhibitors of Calmodulin. Org Lett 2006;8(2):223-5
134. Plante JP, Burnley T, Malkova B, et al. Oligobenzamide proteomimetic inhibitors of the p53-hDM2 proteinprotein interaction. Chem Commun 2009(34):5091-3
135. Azzarito V, Prabhakaran P, Bartlett AI, et al. 2-O-Alkylated para-benzamide alpha-helix mimetics: the role of scaffold curvature. Org Biomol Chem 2012;10(32):6469-72
136. Azzarito V, Miles JA, Fisher J, et al. Stereocontrolled protein surface recognition using chiral oligoamide proteomimetic foldamers. Chem Sci 2015;6(4):2434-43
137. Barnard A, Long K, Martin HL, et al. Selective and Potent Proteomimetic Inhibitors of Intracellular Protein-Protein Interactions. Angew Chem Int Ed 2015;54(10):2960-5
138. Muller S, Laxmi-Reddy K, Jena PV, et al. Targeting DNA G-Quadruplexes with Helical Small Molecules. ChemBioChem 2014;15(17):2563-70
139. Buratto J, Colombo C, Stupfel M, et al. Structure of a Complex Formed by a Protein and a Helical Aromatic Oligoamide Foldamer at 2.1 angstrom Resolution. Angew Chem Int Ed 2014;53(3):883-7
140. Chandramouli N, Ferrand Y, Lautrette G, et al. Iterative design of a helically folded aromatic oligoamide sequence for the selective encapsulation of fructose. Nat Chem 2015;7(4):334-41
141. Long K, Edwards TA, Wilson AJ. Microwave assisted solid phase synthesis of highly functionalized N-alkylated oligobenzamide alpha-helix mimetics. Bioorg Med Chem 2013;21(14):4034-40